Transplant Genomics, Inc.
Clinical trials sponsored by Transplant Genomics, Inc., explained in plain language.
-
New blood tests aim to spot early transplant trouble
Disease control Not yet recruitingThis study is testing two blood tests (TruGraf and TRAC) to see if they can help doctors better monitor kidney transplant patients. The tests look for early signs of organ rejection so doctors can adjust anti-rejection medications sooner. The study will follow 600 kidney transpla…
Sponsor: Transplant Genomics, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New test could spot dangerous viruses before they damage transplanted kidneys
Disease control Not yet recruitingThis study aims to see if regularly checking virus levels in kidney transplant patients can help prevent serious infections that damage the new kidney. Researchers will follow 1,000 patients for a year after transplant, using a new blood test to monitor three specific viruses. Th…
Sponsor: Transplant Genomics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC